RxDoctor Payments Data

Ronald Lakatos, MD

Orthopaedic Surgery of the Spine · State College, PANPI 1093771123

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Riwospine, Inc. at 30.6% of the total. Reporting peaked in 2022 at $1,072 and has fallen 72.6% since, to $293 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in PA, where the typical reported total is $6,283.

$2,942in general payments, 2019–2025

Across 46 payments — averaging $63.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Riwospine, Inc.$900
  • Zimvie Inc.$520
  • Boston Scientific$256
  • Globus Medical$251
  • Medtronic$206
  • Arthrex$205
  • plus $604 from 9 others

What the payments were for

  • Travel & lodging$1,24142%
  • Food & beverage$1,70258%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Riwospine, Inc.1$900
Zimvie Inc.4$520
Boston Scientific17$256
Globus Medical5$251
Medtronic3$206
Arthrex3$205
Providence Medical Technology, Inc.2$146
Nevro Corp.2$118
Si-bone, Inc.3$94
Mid-atlantic Surgical Systems, LLC1$66
Spinesmith Holdings, LLC1$63
Centinel Spine, LLC1$55
Davol Inc.1$23
AbbVie1$20
Abbott1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,942 in reported general payments places this provider in the 35th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$72,786
Medicare patients
152
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib81$1,767
Tizanidine Hcl97$732
Gabapentin56$303
Meloxicam83$288
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$128
Tramadol Hcl34$111
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$101
Prednisone12$40
Alprazolam21$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →